Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ASN004 for Solid Tumors
Recruiting1 awardPhase 1
Fairfax, Virginia
This trial is testing a new drug, ASN004, given intravenously every 3 weeks. The goal is to find the highest safe dose of ASN004 to test in future trials. Up to 43 patients will be enrolled in seven dose levels, with up to six subjects per dose level.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.